ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) Operating income 2024–2025
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) annual operating income history from SEC filings — each fiscal year as reported.
-$19.4MFY2025 · since FY2024: -$1.2M → -$19.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$19.4M | -1498.1% |
| FY2024 | -$1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ASBP financial trends
ASBP RevenueASBP Net incomeASBP Net marginASBP Gross profitASBP Gross marginASBP Operating marginASBP Operating cash flowASBP Free cash flowASBP Capital expendituresASBP Return on equityASBP Stock buybacksASBP Dividends paidASBP Total assetsASBP Total liabilitiesASBP Shareholders’ equityASBP overview →